BLOG

Source: FiercePharma President Donald Trump is pressing ahead with plans to impose steep tariffs on imported pharmaceuticals—starting small but ramping up to 250%—in a bid to push drug manufacturing back to the U.S. The move, paired with a revived “most favored nation” pricing policy, has already spurred major pharma companies

Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.

Source: PharmaVoice A new bill led by two independent senators seeks to ban direct-to-consumer (DTC) pharmaceutical advertising, arguing that promotions drive up drug costs and mislead patients. While some support the move as a step toward transparency, critics claim it could limit patient awareness and hinder innovation in healthcare marketing.

Source: Fierce Biotech The FDA is implementing an AI tool named Elsa to expedite drug application reviews, aiming to process initial submissions, sometimes exceeding 500,000 pages and analyzing it in a matter of minutes. Challenges remain as Elsa sometimes produces inaccurate or unreliable responses so all AI-generated outputs will still

Field representatives often (mistakenly) perceive that virtual speaker programs are not worth the effort. We hear some clients saying that their representatives resist virtual programs because they claim they’re too difficult to set up. They take too much time. Technology is a hurdle. These perceptions have become one of the

Vision2Voice (V2V) is proud to participate in Patient Advocacy Organization (PAO) Action Week™ from June 9–13. Founded by Astellas Pharma Inc., PAO Action Week celebrates the vital work of Patient Advocacy Organizations—more than 1,200 U.S. nonprofits that amplify the voices, needs, and rights of patients, particularly those living with serious